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Abstract
Aim: To describe the burden of tuberculosis (TB) in Cape Town by calculating TB incidence rates stratified by age and HIV-
status, assessing the contribution of retreatment disease and estimating the cumulative lifetime TB risk in HIV-negative
individuals.
Methods: Details of TB cases were abstracted from the 2009 electronic TB register. Population denominators were
estimated from census data and actuarial estimates of HIV prevalence, allowing calculation of age-specific and HIV-stratified
TB notification rates.
Results: The 2009 mid-year population was 3,443,010 (3,241,508 HIV-negative and 201,502 HIV-positive individuals). There
were 29,478 newly notified TB cases of which 56% were laboratory confirmed. HIV status was recorded for 87% of cases and
of those with known HIV-status 49% were HIV-negative and 51% were positive. Discrete peaks in the incidence of non-HIV-
associated TB occurred at three ages: 511/100,000 at 0–4 years of age, 553/100,000 at 20–24 years and 628/100,000 at 45–49
years with 1.5%, 19% and 45% being due to retreatment TB, respectively. Only 15.5% of recurrent cases had a history of TB
treatment failure or default. The cumulative lifetime risks in the HIV-negative population of all new TB episodes and new
smear-positive TB episodes were 24% and 12%, respectively; the lifetime risk of retreatment disease was 9%. The HIV-
positive notification rate was 6,567/100,000 (HIV-associated TB rate ratio=17). Although retreatment cases comprised 30%
of the HIV-associated TB burden, 88% of these patients had no history of prior treatment failure or default.
Conclusions: The annual burden of TB in this city is huge. TB in the HIV-negative population contributed almost half of the
overall disease burden and cumulative lifetime risks were similar to those reported in the pre-chemotherapy era.
Retreatment TB contributed significantly to both HIV-associated and non-HIV-associated TB but infrequently followed prior
inadequate treatment. This likely reflects ongoing TB transmission to both HIV-negative and positive individuals.
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Introduction
Tuberculosis (TB) notifications in South Africa have increased
progressively over the last 20 years, temporally associated with the
growth of the HIV epidemic. South Africa is now the 3
rd highest TB
burdened country in the world [1,2] and is estimated to account for
approximately 25% of the estimated global caseload of HIV-
associated TB [1,2]. However, testing for HIV-infection among TB
cases has remained low due to stigma, doctor reluctance and
operational constraints. The prevalence of HIV-infection in South
African TB cases in 2007 was estimated to be 74%, but this figure
wasextrapolated froma minorityofnotified cases whoweretested in
that year, potentially leading to over-estimation of HIV prevalence
[1,2]. In South Africa in 2007 HIV-testing was performed on 39%
of TB cases with 65% reported positive. However, in 2008 when
HIV-testing was increased to 49% of TB cases, 58% were reported
positive, resulting in a downward re-estimation of national HIV/TB
caseload. Low HIV-testing rates among TB cases therefore con-
stitute a major impediment to our understanding of the epidemi-
ological interaction between TB and HIV at a population level.
Cape Town is a major South African city with a population of
3.4 million people, in which the burden of both HIV and TB are
high [3,4]. The city TB control program is based on a network of
community clinics dispensing rifampicin-based TB treatment
under a 100% directly observed treatment short course strategy
(DOTS) strategy [5,6] and supported by a comprehensive
accredited TB laboratory service [7]. In recent years, there has
been a concerted effort to increase provider initiated HIV testing
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25098within the TB service [8,9]. In 2009, HIV-status was determined
for 87% of all TB notifications, enabling stratification of the
majority of TB cases by HIV-infection status.
We therefore set out to estimate the 2009 age specific TB
notification rates for HIV-infected and HIV-uninfected popula-
tions of the city. TB numerators were abstracted from the 2009 TB
notification database and denominators were estimated from
population census data [10,11] and actuarial estimates of HIV
prevalence [12,13]. Age-specific TB rates were used to define the
contribution of new and retreatment TB at different ages and to
model cumulative risks for new and retreatment TB.
Methods
Population Denominators
The mid-2009 population of Cape Town was estimated using
the National Department of Health/Health Information System
Program, which disaggregates estimates from Statistics South
Africa district using the`Small Area Spacial Layer ` (StatsSA, 2004)
of the 2001 national census [10,11].
Age-specific HIV prevalence was calculated for the City of
Cape Town from the province specific output (Western Cape) of
the ASSA2003 AIDS and demographic model, which is the
current version released by the Actuarial Society of South Africa
[12]. The model represents the HIV/AIDS epidemic and its
demographic impact on the population of South Africa.
Population numbers and age- and sex-stratified HIV prevalence
were used to calculate the denominators needed to calculate TB
notification rates stratified by age, sex and HIV status.
Tuberculosis case definitions
TB case definitions were recorded in the electronic TB register as
per the guidelines for the National TB Control Program as follows
[5]. Transfer in: a case transferred from outside the metropolitan
area. Moved in: a case transferred from a facility within the
metropolitanarea.Newcase:apatientwhohasneverhadtreatment
for TB or who has taken anti-tuberculosis drugs for less than four
weeks. Re-treatment case: a patient who has taken treatment for TB
before and either relapsed, defaulted or had treatment failure.
Treatment after failure: a pulmonary TB patient who is still sputum
smear positive at the end of the treatment period. Treatment after
default: a patient who completed at least one month of treatment
and returns after having interrupted treatment for two months or
more but still with active TB as judged on clinical and radiological
assessment. Smear positive pulmonary TB: a direct sputum smear
was positive on one or more occasion. Laboratory proven TB:
smear positive and/or a positive Mycobacterium tuberculosis culture
obtained from specimens as reported by the National Health
Laboratory Services, Cape Town [7].
HIV-status
Notified patients were defined as HIV-positive if results of
positive HIV serology were recorded in the TB register or if the
patient was recorded to be currently receiving antiretroviral
therapy or co-trimoxazole prophylaxis. HIV-negative status was
defined by a recorded HIV-negative serology result. All other cases
were considered to be of unknown HIV-status.
Cumulative risk analysis
Cumulative risk of TB was modeled using standard life table
analysis [14]. In the absence of longitudinal data, age bands were
used as surrogates for time. Age-specific TB notifications and
adjusted denominators of population at risk for TB incidence in
preceding age bands were used to calculate age specific TB rates.
The cumulative risk at any age band was estimated from the
product of risks of not being infected (1-adjusted notification rate) in
all the preceding age bands. Cumulative analyses were performed
using only the known HIV-negative rates and also including an
allocation of HIV-unknown cases in the same proportion as
occurring among the known HIV-tested cases. As this was a cross-
sectional study these hypothetical cumulative estimates assume
persistence of the current 2009 status quo throughout life [14].
Statistical methods
Simple descriptive statistics were used to characterize and
compare groups of patients using Wilcoxon rank-sum, t-test, and
Chi Square tests as appropriate.
Human Subjects Protection
Since this analysis was performed at population level with
notified anonymous data, ethical review and informed consent was
not obtained.
Cape Town 2009 notification data were reported in a different
analysis by the same authors in an editorial [15].
Results
Cape Town Population
The mid-2009 population of Cape Town was estimated to be
3,443,010 and the age and gender population pyramid for the
population is shown in figure 1. Age-stratified denominators are
given for overall population and for the HIV-uninfected and HIV-
infected population pools (Table 1).
Tuberculosis notifications
In the Cape Town metropolitan area a total of 31,093TB cases
were recorded in the electronic TB register of the TB control
program between January 1
st and December 31
st2009. ‘‘Transfers
in’’ (1,331) and ‘‘moved in’’ (284) cases were excluded from the
analysis. Ofthe remaining29,478newlyregisteredTBcases,12,311
(42%) were smear-positive pulmonary cases and of these, a further
4,175 (14%) confirmed by culture of Mycobacterium tuberculosis.T h e
numbers of all TB notifications, new TB notifications and
laboratory confirmed cases are show stratified by age in table 1.
HIV status was available for 25,740 (87.3%) of whom
12,508(48.6%) were HIV-negative and 13,232 (51.4%) were HIV-
positive. The number of TB notifications (TB burden), which were
of HIV-negative, HIV-positive and unknown HIV-status are
shown, stratified by age in figure 2. There were 2,853cases of
childhood TB notifications in the 0–4 year’s age-group and 1,115
between 5 and 14 years of age. Of the 25,510 adult cases, HIV-
negative burden was greatest between age 20- and 24 years and
HIV-positive between age 30- and 34 years.
Effect of unknown HIV-status on TB rates
HIV-status was unknown in 13% of the total TB notifications,
however testing rates varied considerably across age strata. The
testing proportion was lowest (66%) among 0–4 year-olds, was
highest (91.2%) in adults between 20 and 59 years and lower (82%)
in those above 60 years. HIV-negative rates for 0–4 years may
therefore be underestimated by 34% whereas adult (20–59 years)
under ascertainment was likely less than 10%. For HIV-positives
under ascertainment of numerators together with small denomina-
tor numbers at the extremes of age could combine to affect rate
estimations in the very young and elderly. HIV-positive analyses
weretherefore restrictedto ages 20 to 59 years wherethere washigh
ascertainment of numerators and well-characterized denominators.
Tuberculosis Burden in a Major South African City
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Table 1. The number of tuberculosis notifications (numerators) together with Cape Town population (denominators) stratified by
both 5-year age groups and HIV-status.
Cape Town population TB HIV-negative TB HIV-positive TB HIV-status unknown
Age
strata Total HIV- HIV+ All cases New cases Smear+ All cases New cases Smear+ All cases New cases Smear+
0–4 316078 309448 6630 1582 1559 7 311 291 6 960 948 1
5–9 322819 319326 3493 372 362 19 133 122 11 217 214 6
10–14 312137 311707 430 227 217 98 75 61 17 91 89 29
15–19 304903 301447 3456 988 887 617 197 173 71 251 238 150
20–24 327113 306210 20903 1693 1368 1143 1098 871 408 393 339 240
25–29 330742 287160 43582 1381 1030 906 2537 1909 858 376 307 246
30–34 298919 251725 47194 1015 721 673 2973 2060 986 296 230 166
35–39 257267 224038 33229 1042 657 682 2452 1607 832 268 172 155
40–45 197947 179524 18423 1053 628 662 1584 1006 545 203 133 120
45–49 183414 171395 12019 1076 593 656 954 615 318 215 132 132
50–54 163071 156238 6833 829 477 467 493 308 140 157 91 85
55–59 130157 126738 3419 571 345 320 269 171 62 123 84 65
60–64 106269 104718 1551 315 196 151 105 65 39 73 57 30
65–69 77547 77231 316 195 129 77 34 17 8 50 37 19
70–74 52142 52120 22 72 47 25 11 6 4 24 18 7
75+ 62485 62485 0 97 74 37 6 5 3 41 30 12
Total 3443010 3241508 201502 12508 9290 6540 13232 9287 4308 3738 3119 1463
Tuberculosis case notification numbers for HIV-infected, HIV-uninfected and unknown HIV-status are also shown for new (first episode) and direct smear positive
pulmonary tuberculosis.
doi:10.1371/journal.pone.0025098.t001
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The burden of disease (TB notifications) for new and retreatment
TB stratified by age is shown for HIV-negative individuals in
figure 3. These estimates represent the minimum burden and
include no allocation of cases from those with unknown HIV status.
There were 1,582 cases between ages 0–4 years, with an age-
stratifiednadirof227casesbetween10-and14yearsand higherTB
rates seen with increasing adolescent age. Recurrent disease
constituted 26% (n=3,218) of the total burden of which 84.5%
(n=2,718) had no history of treatment failure or default.
Non HIV-associated TB rates
TB notification rates (cases per 100,000) calculated from the
known HIV-negative new and retreatment TB cases and the
estimated HIV-negative population of Cape Town are shown
stratified by age in figure 4.There were 3 distinct peaks of TB
incidence.Thefirstpeakwasat0–4yearsof511casesper100,000of
which 1.5% were retreatment cases. Following the nadir between
10- and 14 years, TB rates increased rapidly with increasing
adolescent age to a second peak of 553 cases per 100,000 of which
19.2% were due to retreatment TB. The highest TB incidence rate
of 628/100,000 was among individuals aged 45–49 years in whom
retreatment TB constituted 45% of incidence.
Cumulative non HIV-associated TB risk
A modeled estimate of the lifetime risk for HIV-uninfected
individuals of developing either an initial or retreatment episode of
TB is shown in figure 5. The model calculates the hypothetical
cumulative risk for individuals who remain HIV-uninfected and
assumes current TB incidence rates persist throughout their life.
Residents of Cape Town surviving to the age of 70 years and
remaining HIV-uninfected would have a minimum 20% lifetime risk
for having any new TB diagnosis and an estimated 24%after
adjustment by allocation of unknown HIV-status cases. The corres-
ponding lifetime risks for retreatment TB were a minimum of 8.4%
and adjusted rate with unknown case allocation of 9.2%. The
adjusted lifetime rate for smear-positive pulmonary TB was 12% for
new TB and5.5% for retreatment TB. The cumulative risk for
retreatment episodes was twice that expected by allocating equal risks
to initial and subsequent episodes (initial risk squared), indicating that
thosewith a primary treated TB event are at an approximate two-fold
increased likelihood for developing a retreatment episode.
HIV-infected TB burden
The number of new and retreatment HIV-infected notifications
stratified by age is shown in figure 6. These values represent the
minimum burden and include no allocation of cases from those with
unknown HIV status. Retreatment TB cases constituted 30%
(n=3,945) of the total burden of which87.6% (n=3,457) had no
history of treatment failure or default. Retreatment cases occurred at
older age (35vs 32 years p,0.001) and had higher case fatality (6.4%
vs. 5.1% p,0.01) than new TB cases. CD4 cell counts were available
for 3,508 of 3,945 (89%) retreatment cases and 8,307 of 9,287 (89%)
new cases. The median CD4 cell count of retreatment TB cases was
higher(166 cells/uLvs148 cells/uL,p=0.02)thanthatofnewcases.
HIV-infected TB and antiretroviral therapy
1,288 patients were recorded to be receiving ART at the time of
TB notification, which represents 9.7% of total HIV-positive
notifications. The median age of individuals on ART was a little
Figure 2. The numbers of tuberculosis notifications in 2009, which were recorded as HIV-infected, HIV-uninfected and of unknown
HIV-status, stratified by 5-year age group.
doi:10.1371/journal.pone.0025098.g002
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stratified by 5-year age group.
doi:10.1371/journal.pone.0025098.g003
Figure 4. Notification rates for all, new and recurrent tuberculosis cases for HIV-negative residents aged 15 years to 49 years in
Cape Town. HIV-uninfected population denominators derived from the product of Cape Town age population pyramid [10,11] and 1-HIV-
prevalence [12].
doi:10.1371/journal.pone.0025098.g004
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age for Cape Town residents remaining HIV-uninfected.
doi:10.1371/journal.pone.0025098.g005
Figure 6. The numbers of tuberculosis notifications of new and recurrent disease in patients with known HIV-infection, stratified by
5-year age group.
doi:10.1371/journal.pone.0025098.g006
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count moderately lower than non-ART cases (147cells/uLvs
153cells/uL, p=0.058). However, the proportion of patients
receiving ART in whom disease was due to retreatment was
significantly higher compared to that of non-ART cases (43%
versus 28%, p,0.001). The proportion of retreatment cases
following default or failure was lower in the on-ART group (9.4%,
95%CI 7-11.83) compared with non-ART cases (12.6%, 95%
CI 11.5-13.7).
HIV-infected TB rates
Minimum TB notification rates calculated from the known
HIV-positive new and retreatment TB cases and the estimated
HIV-positive population of Cape Town are shown by 5-year age
strata between 20–24 years and 50–54 years in figure 7. The new
HIV/TB notification rate remained relatively stable with
increasing age (4,392 to 4,561 cases/100,000) whereas recurrent
disease rates increased markedly with age from 1,092 at 20–24
years to 2,265 cases/100,000 at 50–54 years.
Discussion
For the first time in a major city in sub-Saharan Africa with high
HIV and TB burden, a very high rate of HIV testing of TB cases
has permitted careful analysis of the burden of HIV-associated and
non-HIV-associated TB stratified by sex and age. The TB
notifications from this city were more than twice the combined
annual caseload of USA and Canada [1] and rates of both HIV-
associated and non-HIV-associated TB was extremely high. TB
incidence rates in HIV-negative were greatest in 45–49 year olds
and very high in the 20–24year olds, and were of similar
magnitude as those reported in the 1940’s in Norway [16]. The
estimated lifetime TB risk of 22% was approximately double that
observed in studies of TB infection acquired during childhood in
United Kingdom in the 1950’s [17,18] and was similar to
estimates of cumulative TB risk in the early 20
th century Europe
prior to advent of chemotherapy [19].
An important finding in this study was that the proportion of the
total TB burden due to retreatment disease (26%) was greater than
that reported for South Africa (18.8%) or the African continent
(9.9%) [1,20]. Retreatment cases may result from failed initial
therapy or subsequent reactivation or re-infection [21–24]. The
proportion of cases reported after treatment failure or default
reflects the cases due to failed initial treatment. Despite an
increased burden of retreatment TB cases in Cape Town the
proportion following failed initial therapy (14.3%) was lower than
that reported for South Africa as a whole (15.7%) or for the
African continent (22%) [1]. Furthermore, HIV-positive cases had
a higher retreatment rate than HIV-negatives but a lower
proportion due to failed prior treatment. Together these data
suggest that the high retreatment rate in Cape Town is unlikely to
be predominantly due to inadequate or poor case management
but is more likely related to the high prevailing force of TB
infection [25–28]. The high cumulative risk for recurrent disease
in HIV-negatives also indicated that following an initial TB
episode there was a two-fold increased risk for subsequent TB
episodes. This increased hazard for subsequent TB episodes
following an initial TB episode confirms previous reports from
Figure 7. Notification rates for all, new and recurrent tuberculosis cases for HIV-positive residents aged 20 years to 54 years in
Cape Town. HIV-infected denominators derived from the product of Cape Town age population pyramid [10,11] and HIV-prevalence [13].
doi:10.1371/journal.pone.0025098.g007
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increased risk may include that these individuals have higher
environmental exposure, (i.e., more TB contacts) or that latent
infection itself may offer some immunologic protection and
treatment may interfere with this immunity.
Non-HIV associated TB varied markedly between age strata
and 3 peaks in TB incidence were observed. The first peak
occurred before 4 years of age. HIV testing was low in infancy and
the therefore even the high HIV-uninfected childhood’s notifica-
tion rate may have been underestimated by as much as 33%. This
TB disease rate is in keeping with a reported annual risk of TB
infection (ARTI) of approximately 4% per annum in young
children in Cape Town [25,26], which has remained largely
unchanged over the last decade [30]. The ARTI in poor
communities of Cape Town TB is maintained by transmission
to young children within households from adults with smear-
positive pulmonary disease [27,31]. Despite limited social
networks, young children have prolonged contact in poorly
ventilated dwellings with extended family members and frequently
share sleeping quarters with adults [27].
Childhood TB notifications rapidly decreased after the age of 5
years to a nadir between 10 and 14 years. This decline in TB
disease occurred despite a high continuing annual TB infection
rate [25-28], a phenomenon that has been widely recognized but is
poorly understood [21]. Whilst it may be speculated that this has
an immunologic aetiology, further research to understand this
phenomenon is warranted. TB notification rates rapidly increased
from the nadir at 10–14 years to a second peak between 20 and 24
years. As TB disease is more frequent soon after infection [16–
19,21] this rapidly increasing incidence is consistent with very high
infection rates (7% per annum) reported among adolescents in
Cape Town [28].
The third peak in TB notification rates occurred at age 45–49
years and consisted of almost equal proportions of new and
recurrent TB disease. Recurrent disease in Cape Town and other
high burdened settings has been reported to result predominantly
from re-infection [22–24]. Multiple re-infections are to be
predicted when the prevailing force of TB infection exceeds 1%
per annum [32,33].
The high lifetime risk for developing infectious pulmonary
disease has serious implications for TB control. An effective TB
contact number is defined as a contact between an infectious
pulmonary cases and a susceptible individual sufficient to result in
TB infection [34]. In this population where 1 in 8 of the HIV-
negative population develops infectious smear-positive pulmonary
TB, the effective contact number should be reduced to less than 12
for long-term epidemic control within the HIV-negative popula-
tion. Historically the effective contact number in the United
Kingdom was estimated to decline from 22 in 1900, to 10 in 1950
and 1 in 1990 [19].
HIV-infected individuals had a 17-fold increased risk of TB
compared with HIV-negative peers and the burden of HIV-positive
TB closely mirrored the prevalence of HIV-infection in the city.
Interpretation of age specificincidenceis morecomplexinthe HIV-
positive population as age is only indirectly related to time from
acquisition of HIV-infection and access to ART is an increasing
confounder. However, there were indications that the rate of new
andretreatment TB maybe differentiallyaffected byHIV-infection.
Whilst the reasons for this are as yet speculative, the younger age of
newHIV/TBcasestogether with a lower CD4cellcount maybe an
indication that some new case TB may be a manifestation of a
transient CD4 decline which occurs following sero-conversion. In
contrast, the older age and higher rate of recurrent disease with age
may reflect a combination of high ongoing risk of TB infection and
HIVdiseaseprogression.IncreasedretreatmentTBamongthoseon
ART may also indicate that re-infection TB is particularly common
in this group. In addition, as evidenced by higher CD4 T cell counts
in the retreatment group on ART, this may reflect longer survival in
an ongoing risk of TB reinfection.
Weaknesses of this study include the analysis of routinely
collected data within a busy TB control program with the
consequential risk of miss-classification of patient category status.
Furthermore, there may also have been unascertained TB cases,
which died before notification to the TB control program. The
denominator estimations were based on an actuarial model of the
South African HIV epidemic (ASSA model) and was not directly
measured. However, the ASSA model is calibrated against the
South African antenatal sero-prevalence surveys performed
annually. The ASSA model has been widely used for health
system planning including by the South African department of
health and treasury. Cumulative risk analyses were based on data
from a single year and can only reflect an estimation assuming
continuation of the status quo. The HIV-testing proportion of 87%
is still not optimal but is considerably higher than national testing
rate and that of any other comparable large population. Whilst
reported rates of multidrug resistant TB prevalence is estimated to
be about 2% in new TB patients and 7% in re-treatment cases
[35], drug susceptibility testing is not routinely performed
according to the National TB program and therefore the role
that drug resistance may play in treatment failure and retreatment
was not possible to evaluate in this study. The strength of the study
is the large number of cases, analyzed within a well functioning TB
control program with high quality laboratory support.
In conclusion, HIV-infection undoubtedly contributes signifi-
cantly to the increased TB caseload noted in recent years.
However, while much of the public health focus has been
understandably directed towards HIV-associated TB, non-HIV
associated TB incidence rates have been underestimated and we
report TB burdens now similar to those recorded in the pre-
chemotherapy era. The high retreatment rates observed in both
HIV-positive and HIV-negative populations do not appear to be
due to failed initial TB therapy but these data are indicative of a
city population that is subjected to an extremely high and ongoing
force of TB infection. In addition to effective TB case
management, it will be necessary to revisit those TB control
measures, which effectively reduced TB transmission in industri-
alized countries before the discovery of TB chemotherapy.
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